NCT05332210 2023-03-08Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia GravisHarbour BioMed (Guangzhou) Co. Ltd.Phase 3 Unknown144 enrolled